Feng Weiting Amends Stake in Golden Matrix Group

TL;DR

Cathy Feng just updated her 13D for GMGI - check the filings for details.

AI Summary

On April 9, 2024, Feng Weiting filed an amendment (Amendment No. 5) to Schedule 13D for Golden Matrix Group, Inc. The filing indicates a change in beneficial ownership of the company's common stock. Feng Weiting's address is listed as 3651 Lindell Road, Suite D131, Las Vegas, NV 89103.

Why It Matters

This filing signals a potential shift in control or significant shareholder activity for Golden Matrix Group, Inc., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and uncertainty.

Key Players & Entities

• Feng Weiting (person) — Filing person and potential beneficial owner
• Golden Matrix Group, Inc. (company) — Subject company
• 3651 Lindell Road, Suite D131, Las Vegas, NV 89103 (address) — Mailing address for Feng Weiting

FAQ

Key Financial Figures

• $0.00001 — INC. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class o

Filing Documents

• gmgi_sc13da.htm (SC 13D/A) — 51KB
• gmgi_ex992.htm (EX-99.2) — 131KB
• 0001477932-24-002032.txt ( ) — 183KB

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration

is hereby amended and supplemented by adding the following at the end thereof

Item 3 is hereby amended and supplemented by adding the following at the end thereof: On January 17, 2024, Ms. Feng was issued 62,500 shares of common stock upon the vesting of certain Restricted Stock Units to purchase shares of common stock of the Company, the terms of which are discussed in Amendment No. 2.

Purpose of the Transaction

Item 4. Purpose of the Transaction

is amended and restated in its entirety by the following

Item 4 is amended and restated in its entirety by the following: The information set forth in Item 3 is hereby incorporated by reference into this Item 4 . The Reporting Person acquired the securities pursuant to the transactions described in Item 3 above. In the future, depending on general market and economic conditions affecting the Issuer and other relevant factors, the Reporting Person may purchase or acquire additional securities of the Issuer or dispose of some or all of the securities she currently owns from time to time in open market transactions, private transactions or otherwise. Except as may occur in the ordinary course of business of the Company, the Reporting Person does not currently have any plans or proposals which relate to or would result in the following described: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; CUSIP No. 381098300 Schedule 13D/A Page 4 of 6 (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any per

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer

is amended and restated in its entirety by the following

Item 5 is amended and restated in its entirety by the following: (a) As of the date of this Amendment, the Reporting Person beneficially owns in aggregate 2,853,415 shares of Common Stock of the Issuer, representing approximately 2.4% of the Issuer's outstanding Common Stock on such date (118,884,144 shares of Common Stock, as confirmed by the Company's transfer agent on such date), but not including the shares of common stock issuable upon the vesting of the RSUs discussed above (in Item 3 of Amendment 2), which have not vested to date. (b) Ms. Feng has the power to vote or to direct the vote and to dispose or to direct the disposition of the shares of Common Stock (and RSUs) which are held directly by Ms. Feng (see Item 5(a) above). (c) The information in Item 3 is incorporated by reference into this Item 5(c) . (d) No other person has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the securities beneficially owned by the Reporting Person. (e) On April 9, 2024, the Reporting Person ceased to be the beneficial owner of more than five percent of the Issuer's common stock.

Contracts, Arrangements, Understanding or Relationships with Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understanding or Relationships with Respect to Securities of the Issuer 10b5-1 Plan Pursuant to the 10b-5-1 Plan, Ms. Feng may sell up to 1,134,842 shares of Common Stock beneficially owned by Ms. Feng, on the open market, subject to the satisfaction of certain conditions, including, among others, the Company's trading price. All sales under the 10b5-1 Plan are to be made in the discretion of Oppenheimer and in accordance with the terms, conditions and restrictions of the 10b5-1 Plan. Pursuant to the 10b5-1 Plan, potential sales begin on January 19, 2024 and will continue until September 21, 2025, or until all of the shares of Common Stock to be sold under the 10b5-1 Plan are sold or the 10b5-1 Plan is otherwise terminated. The foregoing description of the 10b5-1 Plan is qualified in its entirety by the full text of the 10b5-1 Plan, the form of which is included as an exhibit to this Schedule 13D and is incorporated herein by reference.

Material to be Filed as Exhibits

Item 7. Material to be Filed as Exhibits Exhibit No. Description 99.1 Form of Golden Matrix Group, Inc. Notice of Restricted Stock Grant and Restricted Stock Grant Agreement (2022 Equity Incentive Plan)(officer and employee awards – September 2022)(Filed as Exhibit 10.3 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on September 20, 2022, and incorporated by reference herein). 99.2 Form of Rule 10b5-1 Sales Plan (Filed herewith). CUSIP No. 381098300 Schedule 13D/A Page 6 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. April 12, 2024 /s/ Weiting Cathy' Feng Weiting Cathy' Feng

View Full Filing

View this SC 13D/A filing on SEC EDGAR